These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 10524681

  • 1. Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee joints.
    Fernihough JK, Richmond RS, Carlson CS, Cherpes T, Holly JM, Loeser RF.
    Arthritis Rheum; 1999 Oct; 42(10):2103-11. PubMed ID: 10524681
    [Abstract] [Full Text] [Related]

  • 2. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 3. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ, Khosla S.
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis.
    Clemmons DR, Busby WH, Garmong A, Schultz DR, Howell DS, Altman RD, Karr R.
    Arthritis Rheum; 2002 Mar; 46(3):694-703. PubMed ID: 11920405
    [Abstract] [Full Text] [Related]

  • 5. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
    Zhang P, Liu B, Li G, Wu L, Yu M, Ou Y, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):65-8. PubMed ID: 11953064
    [Abstract] [Full Text] [Related]

  • 6. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
    Frystyk J, Vinter-Jensen L, Skjaerbaek C, Flyvbjerg A.
    Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
    [Abstract] [Full Text] [Related]

  • 7. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Panminerva Med; 1998 Jun; 40(2):103-6. PubMed ID: 9689829
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S.
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-6 and insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation.
    Street ME, Seghini P, Ziveri MA, Fieni S, Volta C, Neri TM, Viani I, Bacchi-Modena A, Bernasconi S.
    Growth Horm IGF Res; 2006 May; 16(5-6):365-72. PubMed ID: 17101288
    [Abstract] [Full Text] [Related]

  • 11. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Lösche C, Röllmann R, Schatz H.
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [Abstract] [Full Text] [Related]

  • 12. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
    Han HJ, Kang CW, Park SH.
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
    [Abstract] [Full Text] [Related]

  • 13. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.
    Akanji AO, Suresh CG, Al-Radwan R, Fatania HR.
    Scand J Clin Lab Invest; 2007 Jun; 67(5):553-9. PubMed ID: 17763192
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors.
    Reece EA, Wiznitzer A, Le E, Homko CJ, Behrman H, Spencer EM.
    Obstet Gynecol; 1994 Jul; 84(1):88-95. PubMed ID: 7516515
    [Abstract] [Full Text] [Related]

  • 19. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K.
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.